Your browser doesn't support javascript.
loading
Cyclophosphamide, Bortezomib and Methylprednisolone (CyBorMe) for the Treatment of AL Amyloidosis: Initial Experience From a Single Center.
Jimenez-Zepeda, Victor H; Lee, Holly; Fine, Nowell; McCulloch, Sylvia; Tay, Jason; Duggan, Peter; Neri, Paola; Bahlis, Nizar.
  • Jimenez-Zepeda VH; Tom Baker Cancer Center/University of Calgary, 1331 29th St, NW, Calgary, AB T2N 4N2 Canada.
  • Lee H; Tom Baker Cancer Center/University of Calgary, 1331 29th St, NW, Calgary, AB T2N 4N2 Canada.
  • Fine N; Division of Cardiology, Department of Cardiac Sciences, Libin Cardiovascular Institute of Alberta, Calgary, AB Canada.
  • McCulloch S; Tom Baker Cancer Center/University of Calgary, 1331 29th St, NW, Calgary, AB T2N 4N2 Canada.
  • Tay J; Tom Baker Cancer Center/University of Calgary, 1331 29th St, NW, Calgary, AB T2N 4N2 Canada.
  • Duggan P; Tom Baker Cancer Center/University of Calgary, 1331 29th St, NW, Calgary, AB T2N 4N2 Canada.
  • Neri P; Tom Baker Cancer Center/University of Calgary, 1331 29th St, NW, Calgary, AB T2N 4N2 Canada.
  • Bahlis N; Tom Baker Cancer Center/University of Calgary, 1331 29th St, NW, Calgary, AB T2N 4N2 Canada.
Indian J Hematol Blood Transfus ; 37(4): 675-678, 2021 Oct.
Article en En | MEDLINE | ID: mdl-34744351

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Año: 2021 Tipo del documento: Article